Back to search

Ireland· IE-PA-PA22871/033/001

Ipratropium bromide/salbutamol Azure 0.5 mg/2.5 mg per 2.5 ml Nebuliser Solution

A salbutamol und ipratropium bromid product containing ipratropium bromide monohydrate + salbutamol sulfate, registered in Ireland by Azure Pharmaceuticals Ltd.. The same ATC class is registered in 11 of our 19 countries.

ATC R03AL02

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedIpratropium bromide/salbutamol Azure …ATCR03AL02REGISTER NO.IE-PA-PA22871/033/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Salbutamol und ipratropium bromid is registered in 11 of 19 countries.

Countries holding a registration under ATC R03AL02 (salbutamol und ipratropium bromid), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Salbutamol und ipratropium bromid · ATC R03AL02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Ipratropium bromide monohydrate + Salbutamol sulfate
Manufacturer
Azure Pharmaceuticals Ltd.
Country
Ireland (IE)
ATC code
R03AL02
ATC class
Salbutamol und Ipratropium bromid
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA22871/033/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Salbutamol und ipratropium bromid in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All salbutamol und ipratropium bromid products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Combivent Einzeldosisbehältnissen
  • Belgium · Combivent, Ipratropium Bromide/Salbutamol Neutec
  • Cyprus · Berovent
  • Germany · Combiprasal, Ipramol Steri-Neb
  • Denmark · Combivent, Ipramol Steri-Neb
  • Spain · Bivair, Bromuro De Ipratropio /Salbutamol Neutec
  • Finland · Atrodual, Ipratropium Bromide/Salbutamol Neutec
  • United Kingdom (Northern Ireland) · Combiprasal, Combivent Udvs
  • Greece · Berovent, Demoren
  • Croatia · Ipratropijev Bromid/Salbutamol Cipla, Ipsalvio
  • Iceland · Ipratropium Bromide/Salbutamol Neutec
  • Italy · Almeida, Biwind
  • Luxembourg · Combivent
  • Malta · Ipratropium Bromide/Salbutamol Azure
  • Netherlands · Combivent Unit Dose, Ipramol Steri-Neb
  • Norway · Ipratropiumbromid/Salbutamol Neutec
  • Poland · Ipratropium/Salbutamol Cipla, Iprixon Neb
  • Portugal · Brometo De Ipratrópio + Salbutamol, Combivent Unidose
  • Romania · Ipratropiu/Salbutamol Cipla
  • Sweden · Combivent, Ipratropium/Salbutamol Neutec
  • Slovenia · Ipsalvio

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a41fae7a-9679-4bef-8689-d5912512487e
GET /v1/drugs/a41fae7a-9679-4bef-8689-d5912512487e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nebuliser solution",
  "routes": [
    "Inhalation use"
  ],
  "source": "hpra",
  "atc_all": [
    "R03AL02"
  ],
  "strength": null,
  "pa_number": "PA22871/033/001",
  "substances": [
    "Ipratropium bromide monohydrate",
    "Salbutamol sulfate"
  ],
  "legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "06/03/2026",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0081-136-052"
}

See everything about salbutamol und ipratropium bromid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.